Lien web: http://www.catalent.com/index.php/news-events/news/Catalent-Biologics-and-Cerenis-Therapeutics-Announce-Phase-III-Trial-Of-CER-001-in-Europe-and-North-America-Leveraging-GPEx-R-Cell-Line-Technology